Hyperion Therapeutics Lands $13,000,000 New Financing

  • Feed Type
  • Date
    5/18/2009
  • Company Name
    Hyperion Therapeutics
  • Mailing Address
    601 Gateway Blvd South San Francisco, CA 94080
  • Company Description
    Hyperion Therapeutics, Inc. is a privately held specialty biopharmaceutical company dedicated to improving patients’ lives through the development and commercialization of therapies that address critical unmet needs and underserved patient populations. The Company’s initial efforts are focused in the areas of gastroenterology and hepatology.
  • Website
    http://www.hyperiontx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $13,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.